Artificial intelligence in Nanomedicine
Artificial intelligence brings up to the simulation of human intelligence in machines that are programmed to think like humans and impersonator their actions. The term may also be applied to any machine that exhibits characters associated with a human mind such as learning and problem-solving. When most people hear the term artificial intelligence, the first thing they typically think of is robots.
Artificial
intelligence is created on the principle that human intelligence can be
defined in a way that a machine can easily impersonator it and execute tasks. The
goals of artificial intelligence include learning, reasoning, and observation. The
applications for artificial intelligence are endless. The technology can be
applied to many different sectors and industries. AI is being tested and used
in the healthcare industry for treating drugs and different treatment in
patients, and for surgical procedures in the operating room.
Artificial intelligence can be
divided into two different categories:
· Weak artificial intelligence
· Strong artificial intelligence
The field of
nanomedicine had made substantial strides in the areas of therapeutic and
diagnostic development. For example, nanoparticle-modified drug compounds and imaging agents have resulted
in distinctly enhanced treatment outcomes and divergence efficiency. In modern years, tentative nanomedicine
platforms have also been taken into the clinic, with regulatory approvals for
Abraxane and other products being awarded. As the nanomedicine field has continued
to progress, different methods have been discovered to simultaneously fit in
therapeutic and diagnostic agents onto a single particle, or deliver multiple
nanomedicine-functionalized therapies in unison. Nanomedicine-based
drug delivery is often discovered at fixed doses. A determined challenge in all
forms of drug administration is that drug cooperation is time-dependent,
dose-dependent and patient-specific at any given point of treatment.
To overcome this the challenge, the development towards nanomedicine-mediated co-delivery of
multiple therapies have made the potential of interfacing artificial
intelligence (AI) with nanomedicine to sustain optimization in combinatorial
nanotherapy a reality. Precisely, improving drug and dose parameters in
combinatorial nanomedicine supervision is a specific area where artificial
intelligence can actionably recognize the full potential of nanomedicine. To
this end, this review will inspect the role that artificial intelligence can
have in significantly improving nanomedicine-based treatment outcomes,
particularly in the perspective of combination nanotherapy.
Artificial
intelligence also has applications in the financial industry, where it is used
to detect and ensign activity in banking and finance such as infrequent debit
card usage and large account deposits—all of which help a bank's fraud
department. Applications for AI are also being used to help streamline and make
trading easier. This is done by making supply, demand, and pricing of
securities easier to estimate.
Contact
Alan Jane
Program Manager |
Nanomedicine Meet 2020
Email Id:
nanomedicinemeet@memeetings.com
Comments
Post a Comment